Across North America, healthcare providers are placing greater emphasis on specimen integrity, infection prevention, and standardized blood collection procedures. Rising diagnostic testing volumes and continued improvements in laboratory infrastructure are supporting the adoption of advanced collection tubes, needles, capillary collection systems, and safety devices.

Blood Collection Devices Market Size and Growth

The blood collection devices market size is projected to reach US$ 14,021.79 million by 2030 from US$ 8,713.21 million in 2022. The market is expected to register a CAGR of 6.1% during 2022–2030. Rising diagnostic testing volumes, growing healthcare expenditure, increasing prevalence of chronic and infectious diseases, and greater attention to specimen quality are contributing to sustained demand for blood collection products. The adoption of advanced collection systems is also strengthening growth opportunities across developed and emerging economies.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPHE100001279

Rising Demand for Diagnostic Testing

Increasing utilization of laboratory diagnostics is one of the major factors supporting demand for blood collection devices. Blood samples are required for routine health screening, disease diagnosis, therapeutic monitoring, molecular testing, hematology, immunology, and biochemical analysis. The expansion of preventive healthcare and early disease detection programs is encouraging healthcare providers to perform more diagnostic tests, creating recurring demand for needles, tubes, lancets, blood collection sets, and related products.

Focus on Patient Comfort and Healthcare Worker Safety

Blood Collection Devices Market Growth is increasingly influenced by product innovations designed to improve patient experience and protect healthcare professionals. Safety-engineered needles, retractable devices, closed collection systems, and ergonomic blood collection sets are gaining attention because they can help reduce accidental needlestick injuries and improve procedural efficiency. Manufacturers are also developing thinner needles and improved collection mechanisms to support patient comfort while maintaining specimen quality.

Shift Toward Safety-Engineered Products

The transition from conventional devices toward safety-engineered solutions represents an important trend. Healthcare facilities are increasingly prioritizing products that minimize exposure to bloodborne pathogens and reduce occupational risks. Integrated safety mechanisms, automatic needle shielding, needle retraction technologies, and closed transfer systems are becoming increasingly relevant in hospitals and laboratories. These developments are encouraging manufacturers to compete through product design, usability, safety features, and workflow integration.

Technological Advancements in Collection Systems

Technological innovation is transforming conventional blood collection procedures. Manufacturers are introducing products that combine collection, handling, identification, and transportation requirements into streamlined workflows. Pre-attached holders, advanced tube technologies, automated blood collection systems, and digital preanalytical solutions are helping healthcare providers improve consistency and operational efficiency.for example, offers the BD Vacutainer specimen management portfolio, which includes blood collection and specimen management solutions focused on specimen quality, patient comfort, and staff safety.

Growing Importance of Specimen Quality

Specimen integrity is becoming a major consideration in blood collection because errors during the preanalytical stage can affect laboratory results and increase the need for repeat testing. Healthcare institutions are consequently adopting standardized collection systems and products designed to reduce contamination, hemolysis, incorrect tube selection, and sample handling problems. This trend is encouraging demand for reliable collection tubes, holders, safety needles, blood collection sets, and other supporting devices.

Increasing Adoption of Automation

Automation is emerging as a significant trend across blood collection and specimen management workflows. Automated systems can help standardize collection and processing procedures while supporting productivity in high-volume facilities. Blood banks, diagnostic laboratories, and large healthcare networks are increasingly evaluating technologies that can reduce manual intervention and improve traceability. The integration of automation with digital preanalytics is expected to create additional opportunities for device manufacturers during the forecast period.

Regional Growth Opportunities

North America and Europe continue to represent important markets due to established healthcare infrastructure, high diagnostic testing volumes, and strong adoption of advanced medical devices. Meanwhile, Asia Pacific is expected to provide attractive growth opportunities as healthcare infrastructure expands, diagnostic services become more accessible, and investments in hospitals and laboratories increase. Emerging economies are also witnessing greater awareness of infection prevention and healthcare worker safety, supporting the adoption of modern collection devices.

Top Players in the Industry

• Becton Dickinson and Co

• Terumo Corp

• Cardinal Health Inc

• SARSTEDT AG & Co KG

• Nipro Corp

• Sekisui Chemical Co Ltd

• Thermo Fisher Scientific Inc

• Greiner Bio-One International GmbH

• FL Medical SRL

• IntervacTechnology OU

Competitive Strategies and Product Innovation

Companies are strengthening their positions through product launches, portfolio expansion, technological development, strategic collaborations, and geographic expansion. Competition is increasingly centered on safety, patient comfort, specimen integrity, product reliability, and workflow efficiency. Manufacturers are also focusing on solutions that address the requirements of hospitals, laboratories, blood banks, and outpatient facilities. Continued innovation in safety-engineered and automated devices is likely to influence competitive positioning over the coming years.

Future Growth Outlook

The outlook remains positive as healthcare providers continue to prioritize diagnostic accuracy, patient safety, infection prevention, and efficient clinical workflows. Increasing testing volumes and the expansion of healthcare infrastructure are expected to sustain demand for blood collection products. At the same time, automation, digitalization, and advanced safety technologies are likely to create new opportunities for manufacturers. Companies that combine reliable collection performance with enhanced usability and integrated workflow solutions are positioned to benefit from evolving healthcare requirements.

About US

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us

Contact Person: Ankit Mathur
E-mail:ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish